GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vencanna Ventures Inc (XCNQ:VENI) » Definitions » Cyclically Adjusted Price-to-FCF

Vencanna Ventures (XCNQ:VENI) Cyclically Adjusted Price-to-FCF : (As of Jun. 20, 2024)


View and export this data going back to 1992. Start your Free Trial

What is Vencanna Ventures Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Vencanna Ventures Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Vencanna Ventures's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vencanna Ventures Cyclically Adjusted Price-to-FCF Chart

Vencanna Ventures Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Vencanna Ventures Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Vencanna Ventures's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Vencanna Ventures's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vencanna Ventures's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vencanna Ventures's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Vencanna Ventures's Cyclically Adjusted Price-to-FCF falls into.



Vencanna Ventures Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Vencanna Ventures's Cyclically Adjusted FCF per Share for the quarter that ended in Jan. 2024 is calculated as:

For example, Vencanna Ventures's adjusted Free Cash Flow per Share data for the three months ended in Jan. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Jan. 2024 (Change)*Current CPI (Jan. 2024)
=-0.002/125.0724*125.0724
=-0.002

Current CPI (Jan. 2024) = 125.0724.

Vencanna Ventures Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201404 -0.001 98.920 -0.001
201407 0.000 99.315 0.000
201410 -0.001 99.473 -0.001
201501 -0.001 98.209 -0.001
201504 0.000 99.710 0.000
201507 0.000 100.579 0.000
201510 -0.001 100.500 -0.001
201601 0.000 100.184 0.000
201604 0.000 101.370 0.000
201607 0.000 101.844 0.000
201610 -0.001 102.002 -0.001
201701 -0.003 102.318 -0.004
201704 0.000 103.029 0.000
201707 -0.001 103.029 -0.001
201710 -0.001 103.424 -0.001
201801 0.000 104.056 0.000
201804 0.000 105.320 0.000
201807 0.000 106.110 0.000
201810 0.004 105.952 0.005
201901 -0.004 105.557 -0.005
201904 -0.019 107.453 -0.022
201907 0.000 108.243 0.000
201910 0.001 107.927 0.001
202001 -0.001 108.085 -0.001
202004 -0.001 107.216 -0.001
202007 -0.001 108.401 -0.001
202010 -0.001 108.638 -0.001
202101 -0.001 109.192 -0.001
202104 -0.014 110.851 -0.016
202107 0.036 112.431 0.040
202110 -0.001 113.695 -0.001
202201 -0.002 114.801 -0.002
202204 -0.001 118.357 -0.001
202207 -0.001 120.964 -0.001
202210 -0.002 121.517 -0.002
202301 -0.004 121.596 -0.004
202304 -0.002 123.571 -0.002
202307 -0.003 124.914 -0.003
202310 -0.002 125.310 -0.002
202401 -0.002 125.072 -0.002

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Vencanna Ventures  (XCNQ:VENI) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Vencanna Ventures Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Vencanna Ventures's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Vencanna Ventures (XCNQ:VENI) Business Description

Traded in Other Exchanges
N/A
Address
250 - 6th Avenue South West, Suite 310, Calgary, AB, CAN, T2P 3H7
Top Strike Resources Corp aims to provide investors with a diversified, high-growth, cannabis investment strategy through strategic investments and acquisitions focused throughout the value chain (cultivation, processing, and distribution, including ancillary businesses.
Executives
David Gordon Mcgorman Senior Officer

Vencanna Ventures (XCNQ:VENI) Headlines

No Headlines